This job has expired
Search other jobs It was posted more than four months ago and is no longer active. It stays available to read; other jobs are waiting on our search engine.
Medical Science Liaison, Hematology Oncology - Texas
Is this job for you?
Build my CV Build your CV and see how well you match this role — and every other one.
Track your applications on mobile The free Whileresume app, on iPhone and Android.
The role
Provide clinical and economic value information to payers and formulary decision makers, and communicate complex scientific data to healthcare decision makers, with a focus on hematology and oncology (including prostate cancer).
Identify and train members of the speakers' bureau and ensure they are updated on new data.
Respond to investigator-initiated research proposals and support sponsored research programs.
Build and maintain scientific relationships with Academic Medical Centers, fellows in training, and other key stakeholders.
Lead or participate in cross-functional committees or project teams and mentor other MSLs while maintaining compliance and professional standards.
Seek opportunities to demonstrate value, advance field strategy, and model professional values through tact, collaboration, and innovation.
Identify and train members of the speakers' bureau and ensure they are updated on new data.
Respond to investigator-initiated research proposals and support sponsored research programs.
Build and maintain scientific relationships with Academic Medical Centers, fellows in training, and other key stakeholders.
Lead or participate in cross-functional committees or project teams and mentor other MSLs while maintaining compliance and professional standards.
Seek opportunities to demonstrate value, advance field strategy, and model professional values through tact, collaboration, and innovation.
See the full job post
Responsibilities, requirements, skills and benefits — create your free account.
or
Already have an account?
Log inThis job is closed — these are open
No closely matching jobs yet — here are the most recent ones.